Search Results - "Amagase, Kikuko"

Refine Results
  1. 1

    An Overview of Acetic Acid Ulcer Models —The History and State of the Art of Peptic Ulcer Research by Okabe, Susumu, Amagase, Kikuko

    Published in Biological & Pharmaceutical Bulletin (01-08-2005)
    “…Four types of experimental chronic ulcer models, named acetic acid ulcer models, have been developed to examine the healing process of peptic ulcers, screen…”
    Get full text
    Journal Article
  2. 2

    Protective Effect of TRPM8 against Indomethacin-Induced Small Intestinal Injury via the Release of Calcitonin Gene-Related Peptide in Mice by Fouad, Aliaa, Matsumoto, Kenjiro, Amagase, Kikuko, Yasuda, Hiroyuki, Tominaga, Makoto, Kato, Shinichi

    Published in Biological & pharmaceutical bulletin (01-07-2021)
    “…Transient receptor potential melastatin 8 (TRPM8) is a non-selective cation channel activated by mild cooling and chemical agents including menthol…”
    Get full text
    Journal Article
  3. 3
  4. 4

    G protein-coupled receptor 35 contributes to mucosal repair in mice via migration of colonic epithelial cells by Tsukahara, Takuya, Hamouda, Nahla, Utsumi, Daichi, Matsumoto, Kenjiro, Amagase, Kikuko, Kato, Shinichi

    Published in Pharmacological research (01-09-2017)
    “…[Display omitted] G protein-coupled receptor 35 (GPR35), a receptor for lysophosphatidic acid, is highly expressed in the gastrointestinal tract. Recently,…”
    Get full text
    Journal Article
  5. 5

    Roles of Up-Regulated Expression of ASIC3 in Sex Difference of Acid-Induced Duodenal HCO3 - Responses by Takeuchi, Koji, Ohashi, Yumi, Amagase, Kikuko

    Published in Current pharmaceutical design (01-01-2020)
    “…Although the morbidity of ulcers is statistically higher in males than females, the mechanism of this difference remains unknown. Recent studies show that…”
    Get more information
    Journal Article
  6. 6

    Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility by Satoh, Hiroshi, Amagase, Kikuko, Takeuchi, Koji

    “…Antisecretory drugs such as histamine H2-receptor antagonists (H2-RAs) and proton pump inhibitors (PPIs) are commonly used for the treatment of gastric and…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation by Fujiwara, Ayana, Takemura, Keisuke, Tanaka, Anna, Matsumoto, Misaki, Katsuyama, Masato, Okanoue, Takeshi, Yamaguchi, Kanji, Itoh, Yoshito, Iwata, Kazumi, Amagase, Kikuko, Umemura, Atsushi

    Published in Scientific reports (20-08-2024)
    “…Because hepatic stellate cells (HSCs) play a major role in fibrosis, we focused on HSCs as a potential target for the treatment of liver fibrosis. In this…”
    Get full text
    Journal Article
  11. 11

    Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage by Takeuchi, Koji, Tanaka, Akiko, Kato, Shinichi, Amagase, Kikuko, Satoh, Hiroshi

    Published in Clinica chimica acta (02-04-2010)
    “…Nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin decrease mucosal PGE 2 content by inhibiting cyclooxygenase (COX) activity and produce…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Prostaglandin EP Receptors Involved in Modulating Gastrointestinal Mucosal Integrity by Takeuchi, Koji, Kato, Shinichi, Amagase, Kikuko

    “…Endogenous prostaglandins (PGs) play an important role in modulating the mucosal integrity and various functions of the gastrointestinal tract, and E type PGs…”
    Get full text
    Journal Article
  15. 15

    Protective mechanisms of glutamine in intestinal diseases by Nahla Hamouda, Shizuka Jonan, Haruto Fukatsu, Kikuko Amagase

    Published in Integrativnaâ fiziologiâ (01-12-2022)
    “…Glutamine, the most abundant free amino acid in the human body, is a major molecule utilized by intestinal cells. It has been reported that glutamine is…”
    Get full text
    Journal Article
  16. 16

    Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors by Hayashi, Shusaku, Kurata, Naoto, Yamaguchi, Aya, Amagase, Kikuko, Takeuchi, Koji

    “…Lubiprostone, a bicyclic fatty acid derived from prostaglandin E1, has been used to treat chronic constipation and irritable bowel syndrome, and its mechanism…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Cyclooxygenase (COX)-1 and COX-2 both play an important role in the protection of the duodenal mucosa in cats by Satoh, Hiroshi, Amagase, Kikuko, Ebara, Satomi, Akiba, Yasutada, Takeuchi, Koji

    “…Although nonsteroidal anti-inflammatory drugs often cause ulcers in the duodenum in humans, the role of cyclooxygenase (COX) isoforms in the pathogenesis of…”
    Get more information
    Journal Article
  20. 20

    Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract by Akagi, Michiyo, Amagase, Kikuko, Murakami, Toshiko, Takeuchi, Koji

    Published in Current pharmaceutical design (01-01-2013)
    “…Irsogladine, a mucosal protective drug, was developed in Japan for the treatment of peptic ulcer disease and acute gastritis. This drug is superior to…”
    Get more information
    Journal Article